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Abstract 
Patient safety is a global concern and is the most important domains of health-care quality. Medical error is a major patient safety 
concern, causing increase in health-care cost due to mortality, morbidity, or prolonged hospital stay. A definition for patient safety has 
emerged from the health care quality movement that is equally abstract, with various approaches to the more concrete essential 
components. Patient safety was defined by the IOM as “the prevention of harm to patients.” Emphasis is placed on the system of care 
delivery that prevents errors; learns from the errors that do occur; and is built on a culture of safety that involves health care 
professionals, organizations, and patients. Patient safety culture is a complex phenomenon. Patient safety culture assessments, 
required by international accreditation organizations, allow healthcare organizations to obtain a clear view of the patient safety 
aspects requiring urgent attention, identify the strengths and weaknesses of their safety culture, help care giving units identify their 
existing patient safety problems, and benchmark their scores with other hospitals.  
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Introduction 
Since patient safety was first brought to light in the 1990s, 
studies have shown a staggering number of patients harmed 
by preventable medical errors. These errors include systems 
failures, human factors, complicated technologies, powerful 
drugs, prolonged hospital stays, and cost-cutting measures, to 
name a few. Medical errors can cause serious injury or death 
and result in billions of dollars in excess health care costs 
nationwide each year. WHO estimates that one out of every 10 
patients worldwide are impacted by these errors. Death may 
not quite be the final cure for life’s ills that Socrates imagined. 
Recent safety issues imposed by healthcare providers are 
merely medication safety, provider patient ratio, length of 
physician consultation, medical supply shortages, quality 
reporting, antibiotic resistance, sepsis, unnecessary 
emergency hospitalizations, poor diagnosis, wrong prescribing 
and treatment etc.  A good health system aims to deliver the 
best possible care to the individual patient while at the same  
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time being responsive to the health needs of the entire 
population it serves. For many health systems worldwide, 
resources are an important limitation. Commercialism and 
profit orientation in medicine are an important cost driver. 
Similar controversies exist with regard to improvements in 
quality and fairness of healthcare delivery. It is increasingly 
hard to find areas of life into which commercialism has not 
encroached. The corrosive effects of advertising and 
commercialization are more damaging because of the ways 
modern societies have come to rely on physicians, and are 
often made less healthy in the process. Here it is important to 
remember that commercial forces not only respond to 
markets, but work diligently to create markets. A prime 
example is pharmaceutical advertising to the public. Drug 
advertisements influence patients to ask their physicians 
about drugs that have been promoted. 
 
Commercialism in Healthcare Service 
Healthcare Commercialism is defined by the IHC Forum as, 
“transforming an employer's health benefit plan into one that 
puts economic purchasing power—and decision-making—in 
the hands of participants. This is best achieved by supplying 
employees with the decision-making information and support 
tools they need, along with financial incentives, rewards, and 
other benefits that encourage personal involvement in altering 
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health and health care purchasing behaviors. Commercialism 
in health care is an application of operating and managing 
principles typically found in business and commerce       
(financial incentivizing, profit-making, competition, 
marketing/advertising, and focus on the bottom line) to health 
care delivery. The US health care system ranks the highest on 
commercialism among Western industrialized democracies. 
Commercialism poses a threat to medical professionalism, 
patient care, and even the integrity of science, which is a 
foundation of our trust in medicine and medical 
professionalism. This is a timely topic that is getting some 
attention in the bioethics and medical literature. The idea of 
the profit motive in healthcare and the impact that it has on 
the professional practice of nurses and physicians should be 
thoroughly judged. The public healthcare systems have always 
had various weaknesses, which the capitalist media have 
relentlessly exploited. A private healthcare sector is nearly 
always active alongside the public system, providing parallel 
provision for those who can pay cherry-picking profitable 
services, offering ‘hotel’ style hospital accommodation, short 
waiting times for treatment – i.e. in general offering a model 
of a commodified service that looks attractive precisely 
because it is expensive. However, the most important 
common factor in the success of capital’s drive to convert 
state-funded health care into a profit-making commodity has 
undoubtedly been the wider hegemony of neoliberalism, both 
as a system of social practices and as a system of ideas. In 
Germany for example, private hospitals treat patients who are 
older on average and who have more serious health conditions   
than those in public hospitals.  The data also show   that   
private   for-profit   hospitals   are   better equipped to treat 
difficult cases and more complex pathologies.  Moreover, a 
larger proportion of beds in these hospitals are reserved for 
emergency room and intensive care patients [1-5]. 
 
Medication Safety 
Close to 6,800 prescription medications and countless over-
the-counter drugs are available in the United States.  It is 
estimated that in 2019, 4.25 billion retail prescriptions will be 
filled throughout the United States [6]. To further complicate 
a practitioner's responsibility during patient care, there are 
thousands of health supplements, herbs, potions, and lotions 
used by the public regularly to treat their health problems [7]. 
Each year, in the United States alone, 7,000 to 9,000 people 
die as a result of a medication error. The total cost of looking 
after patients with medication-associated errors exceeds $40 
billion each year [8]. The underlined causes are many – 
distractions, distortion, illegible writing, over/under dosing, 
SALAD, wrong metric measures, error induced kidney/liver 
dysfunction, wrong duration, use of abbreviations, 
supplement overload, wrong indication or direction, 
negligence, prescribing high risk medications etc. [9-13]. The 
cost of medication errors worldwide has been estimated as 
US$42 billion/year [14, 15]. Doctors in US incorrectly prescribe 
antibiotics in nearly a third of cases. Study finds more than half 
of US population receives prescription annually and estimates 
‘inappropriate’ prescriptions in doctor’s office setting at up to 
30% [16]. NHS medication errors raise fears thousands could 
be dying because of 237 million mistakes every Year, some 237 
million errors are made annually [17]. In India, studies done in 
Uttarakhand and Karnataka have documented ME rate to be 
as high as 25.7% and 15.34%, respectively, in hospitalized 
patients. 
 
Nurse/Patient Ratio 
Despite progress in the healthcare industry toward achieving 
goals, nurse managers and administrators working on hospital 
units continue to struggle with knowing what constitutes the 
right number and quality of nurses matched to patients' needs 
to achieve clinical outcome targets. Consider that in 2016, 
62.2% of the country's 2.6 million nurses worked in hospitals 
with a median pay of $68,450 per year [18]. With salaries 
making up nearly half of U.S. hospitals' expenses and nursing 
comprising about 30% of salaries, effective management of 
nursing resources, including staffing, is imperative for meeting 
financial outcomes. Higher nurse staffing and richer skill mix 
are associated with improved patient outcomes [19]. In 
addition, nurses provide up to 80% of primary healthcare. 
Thus, dissatisfaction with the nursing care may indicate poor 
healthcare quality and decreases the achievement of 
standards [20]. 
 
Length of Physician Consultation 
Primary care-driven health systems are effective at reducing 
disease, mortality and promoting a more equitable 
distribution of health worldwide. As the global population 
increases, the demand for primary care is also growing in both 
economically developed, low-income, middle-income 
countries. This is leading to an array of different consultation 
lengths, with concerns among primary care physicians 
worldwide about the impact of shorter consultations [21, 22]. 
Average consultation length is also used in the primary care 
monitoring tool as an outcome indicator [23]. Consultation 
length is affected by the number of topics discussed with the 
patient; Consultation length often varies from one country to 
another and is determined by both patient's and doctor's 
characteristics; can be attributed to GP, patient and practice 
characteristics. While Deveugele et al. found that a longer 
consultation length was linked to females and older age. 
Howie et al. further discuss the issue of less attention being 
given to psychosocial issues in consultations [24, 25]. In USA 
the average consultation length has increased steadily to over 
20 min [26], more than 15 min in Canada [27] and less than 15 
minutes in Australia [28]. Comparing this, terrible found in 
Hongkong and Afghanistan (around 3 min), in China and India 
(2 min) and less than 1 min in Bangladesh [29- 33]. 
 
High WTC 
Waiting is a common phenomenon in the doctor's waiting 
room. High number of patients, shortage of staff and aging 
equipment are among the factors contributing to a lengthy 
waiting time. At the emergency department (ED), prolonged 
Commentary PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                         2019, Vol. 10, No. 1, Article 7                     INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i1.1639 
3 
 
wait times have been found to be associated with increased 
morbidity and mortality, and decreased patient satisfaction 
[34]. Although delays in care delivery are common—and 
unpleasant—occurrences in both public and private health 
care systems, there are few reliable data with which to 
determine the prevalence, degree, or nature of the problem. 
Patient waiting time in hospital emergency to receive the first 
treatment step was 66 min in Australia [35], 45 min in USA [36], 
50 min Iran [37] and 64 min Turkey [38].  According to SETS, 
care to be initiated in life-threatening emergencies (receiving 
immediate care), urgent conditions (to be seen within 20 
minutes) [39]. 
 
Shortage of Physicians 
The world health organization predicts that the world needs 
an additional 10 million health care workers by 2030 [40]. 
Between 2000 and 2030, the number of people in the United 
States over the age of 65 was expected to double. This elderly 
population makes twice as many physician visits as those 
under 65 [41]. More hospital staff along with physicians will be 
required with population growth. Interestingly, South Asian 
countries are lack of hospitals comparing to that. Nearly 86% 
of all the medical visit in India are made by rurales with 
majority still travelling more than 100 km to avail health care 
facility of which 70-80% is born out of pocket landing them in 
poverty. Government succeeded in generating infrastructures 
in urban area but fail to do so in rural, sustaining 70% of Indian 
population [42]. However, The Times of India claims healthy 
doctor-patient ratio, 1:921 [43, 44], which is much fewer 
reported in Nepal (2.28 doctors, nurses, and midwives per 
1000 population) [45], worst in rural Bangladesh (1.1 for 10000 
people) [46]. 
 
Shortage of Hospital Supply 
Drug shortages have become all too common and affect all 
aspects of the health care delivery system. The increased 
number of drug shortages has had a negative impact on 
patient care as well as costly financial implications. Shortages 
of critical drugs such as chemotherapy agents, analgesics, 
injectable nutritional supplements, anesthetics, anti-
infectives, and cardiovascular agents are common [47-50]. The 
impact of drug shortages is multifaceted, with over 50% of 
health care practitioners believing that shortages have 
influenced practice and resulted in inferior patient care [51]. A 
Canadian study relayed anesthesiologists’ opinion that drug 
shortages were responsible for prolonged recovery times, 
delayed surgical procedure scheduling, and increased recovery 
cost. Nearly half of them (49%) felt shortages were the impetus 
for the administration of inferior anesthetics. Drug shortages 
often impact vulnerable populations including cancer patients 
or neonates, for whom few, if any, equivalent alternatives 
exist; shortages may result in clinical complications, as 
exemplified by selenium shortages. Drug shortages may also 
force practitioners to prescribe infrequently used medications 
and concentrations, which can lead to medication errors as 
demonstrated with prior fentanyl shortages. Drug shortages 
have also impacted life outside of patient care; for example, a 
planned execution in Oklahoma was delayed due to a drug 
shortage [52]. 
 
Quality Reporting by Hospital Staffs 
IRSs are and will continue to be an important influence on 
improving patient safety. However, they are not the panacea 
that many believe them to be. They have several limitations 
that should be considered. Most of these limitations stem from 
inherent biases of voluntary reporting systems. These 
limitations include: i) IRS can’t be used to measure safety 
(error rates); ii) IRS can’t be used to compare organizations; iii) 
IRS can’t be used to measure changes over time; iv) IRS 
generate too many reports; v) IRS often don’t generate in-
depth analyses or result in strong interventions to reduce risk; 
vi) IRS are associated with costs. IRS do offer significant value; 
their value is found in the following: i) IRS can be used to 
identify local system hazards; ii) IRS can be used to aggregate 
experiences for uncommon conditions; iii) IRS can be used to 
share lessons within and across organizations; iv) IRS can be 
used to increase patient safety culture. Moving forward, 
several strategies are suggested to maximize their value: i) 
make reporting easier; ii) make reporting meaningful to the 
reporter; iii) make the measure of success system changes, 
rather than events reported; iv) prioritize which events to 
report and investigate, report and investigate them well; v) 
convene with diverse stakeholders to enhance the value of IRS 
[53-57]. 
 
Access to Healthcare 
According to the National Rural Hospital Association, 
“Currently one in three rural hospitals is in financial risk. At the 
current rate of closure, 25% of all rural hospitals will close 
within less than a decade in USA.” [58] A relatively similar 
situation found in China. Chinese patients often choose to 
directly access higher level hospitals, thus bypassing primary 
care facilities. As a result, higher level hospitals are 
overcrowded, while primary care facilities remain 
underutilized [59]. Conversely, poor housing condition, unsafe 
drinking water, lack of sanitation, use of biomass fuels, 
exposure to environmental odds as a part of the livelihood 
among the marginal population group often increase the risk 
of numerous health problems in India. Twelve percent of 
critically ill patients remain untreated in the less developed 
villages [60]. According to WHO, 5.9 million children under 5 
years of age died in 2015, with a global under-five mortality 
rate of 42.5 per 1000 live births. Levels of child mortality are 
higher in developing countries. Moreover, leading causes of 
child death in the post-neonatal period were pneumonia, 
diarrhea, injuries and malaria [61]. 
 
Hospital Acquired Sepsis 
Astonishingly, it seems that healthcare access and HCV 
prevalence are related in Pakistan; it is estimated that 70% of 
new HCV infections in Pakistan are attributed to routine 
medical procedures. Particularly concerning are infections 
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caused by contaminated syringes, which are so prevalent in 
the healthcare settings. Villages are gripped by fear; no one 
knew whose life would be taken next by the deadly virus [62]. 
Nosocomial infections, otherwise known as hospital-acquired 
infections, are those infections acquired in hospital or 
healthcare service unit that first appear 48 h or more after 
hospital admission or within 30 days after discharge following 
in patient care. HAP is the second most common nosocomial 
infection, and is the most common hospital infection leading 
to death in critically ill patients [63]. European acute care 
hospitals estimated the prevalence of healthcare-associated 
infections to be 6%; of these, UTI was the third most common 
infection (19%). Based on this, the annual health burden of 
hospitalized patients with UTI was estimated to be 81.2 
disability-adjusted life years per 100 000 individuals in the 
general population [64]. Healthcare-associated infections 
occur in both adult and pediatric patients. Bloodstream 
infections, followed by pneumonia and urinary tract infections 
are the most infections in children, urinary tract infections are 
the most common healthcare – associated infections in adults 
[65] 
 
Availability of Essential Drugs 
Worldwide, many countries have developed a list of essential 
medicines for children to improve prescribing. The WHO 
recommends that each country evaluate and adapt the list in 
order to create a list of essential medicines that is appropriate 
for its own environment. Specialty drugs are administered to 
less than 1% to 2% of the US population, yet they account for 
38% of US prescription drug costs. By 2018, US specialty drug 
costs are expected to account for 50% of all US prescription 
drug costs [66]. In China, access to essential medicines for 
children is hampered by low availability. WHO has estimated 
that at least one-third of the world’s population does not have 
regular access to essential medicines [67]. Among Asia pacific 
countries, Korea was a country where more medicines were 
available than other countries [68]. A survey of the availability 
and price of 32 medicines for chronic diseases in six low- and 
middle-income countries (Bangladesh, Brazil, Malawi, Nepal, 
Pakistan and Sri Lanka) concluded that improvement of 
governance and management efficiency, and assessing local 
supply options, may improve availability of essential drugs. 
Prices could be reduced by improving purchasing efficiency, 
eliminating taxes and regulating mark-ups [69]. In Canada, 
there is no list or central source of information related to 
safety, efficacy and tolerability of medication forms and 
formulations for children [70] and we cannot think of its 
existence in south Asian countries.  
 
High Prices of Drugs and Health Services 
Retail prescription drug spending in the US has been estimated 
at over US$340 billion annually, with projected growth to 
nearly US$600 billion by 2025, accounting for more than 10% 
of total healthcare spending in the US [71, 72]. High costs of 
new drugs and price increases for existing products have 
brought criticism and political interest in the drug pricing 
debate over rising drug prices as well as cost effectiveness and 
affordability [73-76]. Drug price transparency has been argued 
as a potential solution to improve affordability within the US 
and abroad as it would improve the negotiating position for 
purchasers around the world [77]. According to a March 2017 
Bloomberg article, “in the U.S., $15 of every $100 spent on 
brand-name drugs goes to middlemen…[and] the largest 
share, about $8, goes to benefit managers” [78]. Patients are 
the central figures in any healthcare system, and although they 
are often the victim of misaligned incentives, they also bear 
some responsibility for rising costs. Typically, patients are 
motivated to spend as little as possible out of pocket. India is 
the world's largest democracy, with an independent media 
and strong civil society. However, India ranks 130 on 2018 out 
of 189 countries HDI [79]. Poor households spent nearly 15% 
of their monthly income on healthcare in India [60].  
 
Justified Use of Biotech Products 
Biologic agents, which are produced or derived from a living 
organism, are the most rapidly growing class of specialty drugs, 
and hold promise to revolutionize the management of a range 
of chronic medical conditions [80, 81]. The challenge, 
however, is reconciling the potential therapeutic benefit with 
the high cost of these agents. Specialty drugs contribute 
significantly to the inpatient diagnosis-related group payment 
system, often with unproved benefits over less-expensive 
therapies. These medications often may be more appropriate 
for initiation in the ambulatory setting, after the mechanism of 
payment for continued therapy has been established. As 
healthcare costs rise and reimbursements decrease, 
healthcare organization leadership and clinical providers must 
collaborate to provide high-value healthcare. Medications are 
a key driver of the increasing cost of healthcare, largely as a 
result of the proliferation of expensive specialty drugs, 
including biologic agents. Loosely defined based on their high 
costs, the need for special handling protocols, and close 
patient monitoring, specialty drugs are projected to account 
for 50% of the total medical expenditure by 2019 [82].  
 
Antibiotic Resistance  
Antibiotic treatment is one of the main approaches of modern 
medicine, which is used to combat infections. The “golden era” 
of antibiotics ranged from the 1930s to 1960s, which gave rise 
to many antibiotics [83]. In 2018, GLASS reveals widespread 
occurrence of antibiotic resistance among 500 000 people with 
suspected bacterial infections across 22 countries. The most 
commonly reported resistant bacteria were Escherichia coli, 
Klebsiella pneumoniae, Staphylococcus aureus, and 
Streptococcus pneumoniae, followed by Salmonella spp. 
“Some of the world’s most common – and potentially most 
dangerous – infections are proving drug-resistant,” –as stated 
by the director of WHO’s Antimicrobial Resistance Secretariat 
[83]. AMR poses a serious global threat of growing concern to 
human, animal, and environment health. This is due to the 
emergence, spread, and persistence of MDR bacteria or 
“superbugs.” MDR bacteria exist across the animal, human, 
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and environment triangle or niche and there is interlinked 
sharing of these pathogens in this triad. The plausible causes 
of “the global resistome” or AMR include excessive use of 
antibiotics in animals (food, pets, aquatic) and humans, 
antibiotics sold over-the-counter, increased international 
travel, poor sanitation/hygiene, and release of 
nonmetabolized antibiotics or their residues into the 
environment through manure/feces. These factors contribute 
to genetic selection pressure for the emergence of MDR 
bacterial infections in the community. Recently, the global 
consumption of antimicrobials in livestock has indicated the 
hotspots of antibiotics use across the continents that will have 
economic and public health impacts in the years to come. In 
food animals, antibiotics are commonly used in cattle, chicken, 
and pigs and it is projected that in 2030 such use will increase 
up to 67% in the most populated countries of the world. 
Furthermore, as many antibiotics are often inappropriately 
prescribed, a more personalized approach based on precise 
diagnosis tools will ensure that proper treatments can be 
promptly applied leading to more targeted and effective 
therapies. However, in more general terms, also the overall 
use and release of antibiotics in the environment needs to be 
better controlled [84-87]. 
 
Unnecessary Emergency Hospitalizations 
As concern grows in most countries over increasing health care 
costs, more attention is focused on reducing waste and 
unnecessary services. Reducing avoidable emergency 
department (ED) visits is an important health system goal. 
Around 15% of ED visits end in inpatient admission [88, 89]. A 
significant number of 'avoidable' ED visits reported by National 
Hospital Ambulatory Medical Care Survey from 2005 to 2011 
for mental health and dental conditions, where the ED is not 
fully equipped to treat [90]. In the US, the Centers for 
Medicare & Medicaid Services has implemented the first 
financial penalties on hospitals for excessive readmissions. 
Attention likely will be increasingly directed to all 
hospitalizations because readmissions represent only 
approximately 9% of hospital admissions, and to avoidable ED 
visits because of the expense of providing care in this setting 
and its tendency to lead to unscheduled hospital admissions 
[91]. Because some visits are preventable, they may indicate 
poor care management, inadequate access to care, or poor 
choices on the part of patients. ED visits for conditions that are 
preventable or treatable with appropriate primary care lower 
health system efficiency and raise costs. An estimated 13% to 
27% of ED visits in the United States could be managed in 
physician offices, clinics, and urgent care centers, saving $4.4 
billion annually [92-94]. 
 
Poor Health Diagnosis 
Both clinicians and patients rely on an accurate diagnostic 
process to identify the correct illness and craft a treatment 
plan. Achieving improved diagnostic accuracy also fulfills 
organizational fiscal, safety, and legal objectives. ‘Improving 
Diagnosis in Health Care’, report by Institute of Medicine in the 
USA concluded that most people will likely experience a 
diagnostic error in their lifetime [95]. Every nine minutes, a 
patient in a U.S. hospital dies because a diagnosis was wrong 
or delayed -- resulting in 80,000 deaths a year [96]. Terms such 
as overdiagnosis, underdiagnosis and undiagnosed are now 
frequently used, but their relationship to diagnostic error 
remains undefined [97]. Some research suggests that 40% of 
people in the vegetative state are misdiagnosed [98]. Because 
the clinical features of FD overlap with those of other 
disorders, errors and delays in diagnosis are common [99]. 
Despite being an extensively studied condition, the causes of 
ADHD remain poorly understood and substantial in children, 
controversy exists regarding its correct diagnosis [100]. In a 
retrospective analysis of clinical trials, 63% of deceased 
patients who were clinically diagnosed with AD while alive 
were found to have AD with other pathology [101]. The rate of 
misdiagnosis of patients with bipolar receiving outpatient 
treatment was quite high and they often received a 
misdiagnosis of depression [102]. Laryngeal edema has been 
associated with a mortality rate of 12–40%, and in many 
undiagnosed cases, family history and recurrent skin and 
abdominal attacks since childhood could have informed the 
correct diagnosis [103]. 
 
Wrong Dispensing  
Dispensing errors occur in clinical and community pharmacy 
and commonly involve supply of the wrong drug, the wrong 
strength and the wrong form of medication [104, 105]. They 
occur at an average rate of 4 in 250 prescriptions (1.6%) in 
pharmacies in the United States [106], and incidences up to 
45% have been reported in different pharmacy settings [107]. 
A study in the Netherlands showed that 41% of all medication 
incidents in community pharmacies related to information 
technology, were about choosing the wrong drug. One third of 
incidents were associated with confusion of similar drug 
names and nearly half were associated with drug strength 
confusion [108]. Drug strength confusion can happen when 
two strengths of the same drug look alike, e.g. 3.75 mg and 
0.375 mg pramipexole [109]. Drug name and strength 
confusion are serious issues as they are preventable errors 
with potential detrimental impact on clinical practice and 
patient safety [110, 111]. 
 
Lack of Therapeutic Guideline Implementation 
Research indicates that clinical guidelines are often not 
applied. The success of their implementation depends on the 
consideration of a variety of barriers and the use of adequate 
strategies to overcome them. Despite the growing number of 
guidelines, their use in practice is frequently reported as being 
unpredictable, often slow and complex. It is estimated that 
about 30%–40% of patients receive treatment that is not 
based on scientific evidence, and 20%–25% receive treatments 
that are either not needed or potentially harmful [112,113]. 
Guideline adaptation has been defined as a systematic 
approach to modify and contextualize evidence-based 
guidelines to suit implementation in the local healthcare 
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system. The process provides an opportunity to systematically 
consider transferability of recommendations across different 
settings, including variation in needs, values, costs, and 
availability of resources [114]. In India, clinical guidelines, also 
called standard treatment guidelines (STGs), are developed at 
the national and state levels and by a wide range of agencies. 
However, the quality of these guidelines is uncertain [115]. 
 
Poor Vaccination 
Of the nearly 10 million children who die each year before 
reaching their fifth birthday, WHO (World Health Organization) 
estimates that 2.5 million die from diseases that could be 
prevented with currently available or new vaccines [116]. 
However, in the United States it is estimated that 40,000–
80,000 people die annually from VPDs, while hundreds of 
thousands more are hospitalized. The majority of cases and 
99% of the deaths from VPDs are in older adults [117]. Yet, 
people continue to challenge the evidence and refuse 
vaccinations in many parts of the world. Vaccine hesitancy is 
the refusal of people to take vaccines or a delay in vaccine 
acceptance despite vaccination offers from health authorities. 
This behavioral phenomenon is context- and vaccine-specific. 
HL is independently associated with several undesirable health 
outcomes, including poorer overall health status, 
hospitalization, mortality, and healthcare costs [118]. The 
Philippine dengue vaccination is the only mass dengue 
vaccination to date with more than 800,000 individuals 
vaccinated. Vaccination controversy due to perceived 
increased risk of serious dengue illness and death with the 
media associating the vaccine program to politics and 
corruption has caused low vaccine acceptability [119]. Olive 
Healthcare was found to be manufacturing Enclomiphene 
(Estrogen receptor antagonist), a drug that is approved neither 
in India nor elsewhere [120]. Point is the same company 
supplied rancid Vitamin A capsules in Bangladesh which 
caused sickness (experiencing vomiting sensation and feeling 
unwell) in children of Chittagong, Cox’s Bazaar and Lakhimpur 
among other places of Bangladesh, back in 2013 [121]. 
 
Pharmacists Role 
Medication errors are common in community pharmacies. 
Safety culture is considered a factor for medication safety but 
has not been measured in this setting. Both the discovery and 
reporting of medication errors can be improved by creating an 
environment where consultation about medication regimes 
are promoted between members of a network and with 
pharmacists. Understanding the safety culture of community 
pharmacies can help identify areas of strength and those that 
require improvement [122]. Standardized patient safety 
course should be considered in the curriculum for junior 
pharmacy students to improve their attitude toward patient 
safety. The World Health Organization (WHO) has also 
introduced an inclusive patient safety curriculum [123]. With 
the shifting role of community pharmacists towards patient 
education and counselling, they are well-positioned to conduct 
a post-discharge home visit which could prevent or solve drug-
related problems [124]. Close attention to patient safety 
associates with lowered incidences of adverse events in 
hospitals. Pharmacists are well positioned to facilitate the in-
patient care and discharge process by performing medication 
reconciliation, identifying patients with poor health literacy or 
non-adherence, and providing tailored discharge counselling 
[125]. Both the ACCP and ASHP have identified CPs as tools for 
pharmacists to provide cost-effective patient care plans, 
integrate pharmaceutical services, institutional culture, and 
partake leadership position in the development and 
implementation of the multifaceted pharmaceutical care 
[126]. Pharmacists have the unique education and training to 
identify MNA events early, as well as developing strategies to 
mitigate or resolve MNA related issues [126-130]. Pharmacists 
are not alone in their quest for patient safety and quality care. 
Still their role is significant in patient-care and safety 
measurement.  
 
Conclusion 
The expectation of the health care system is better care for 
patients, care that is standards-based and outcomes-driven. 
This expectation is founded on the dual principle that every 
patient deserves to be safe and every patient deserves optimal 
medication therapy. Community pharmacists most frequently 
initiated practical issues, but explored patients’ medication 
beliefs less adequately. Inadequate patient counselling during 
the transition is a contributing factor. They must adapt their 
communication to address the wide variety of patients’ drug-
related problems during these home visits and achieve 
patient-centered communication. It imparts increased 
patients’ satisfaction, better recall of information and 
improved health outcomes and requires active participation of 
both the pharmacist and the patient. Patients should be 
encouraged to express their needs and concerns regarding 
their medication, which pharmacists should address to 
support patients in making informed decisions. It is important 
to discuss patient experiences, beliefs and adherence issues 
pro-actively, since not all patients might express these issues 
themselves. In pharmaceutical treatments, a unique pattern of 
social network in each healthcare setting can steer behaviors 
within organizations towards risk reduction in such 
environments. Gaining insight in the communication during 
these home visits could be valuable for optimizing these visits; 
and consequently, to improve patient safety at readmission to 
primary care. 
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